Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
Phone +1 514 6316775 Fax +1 514 6311867 www.novartis.com
Novartis, a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. Novartis delivers innovative medicines and vaccines to Canadians and healthcare professionals that make important contributions to improving and saving lives. It is headquartered in Dorval, Quebec.
In just over a decade, Novartis Pharmaceuticals Canada has introduced more than 25 new medicines. These treatments have had an important impact on patients suffering from a wide variety of major illnesses, such as: chronic obstructive pulmonary disease (COPD), cystic fibrosis, multiple sclerosis, cancer, age-related macular degeneration and metabolic disease, asthma and osteoporosis. Patients who have had an organ transplant have also benefited from the company’s innovative portfolio.
In 2012, the company invested close to $100 million in research and development in Canada. Novartis Pharmaceuticals Canada Inc. employs more than 600 people in Canada. For further information, please consult www.novartis.ca.
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs,…
The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt…
Pushback from drug companies on Canada’s newest drug pricing regulations has led the country’s regulatory…
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for…
John L. Wallace of Antibe Therapeutics highlights how Canadian innovation stands to put the country at the…
Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to…
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied…
Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to…
A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial…
Canada is the only developed country with a universal healthcare system that does not provide universal coverage of…